Bone Marrow Transplantation Using HLA-Matched Unrelated Donors for Patients Suffering from Severe Combined Immunodeficiency

Hematology/Oncology Clinics of North America

Volumn 25, Issue 1, 2011, Pages 63-73

  Grunebaum, Eyal ^a   Roifman, Chaim M ^a  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Immunodeficiency; Long term; Transplantation; Unrelated

Indexed keywords

PREDNISONE; STEROID;

ALLOGENIC BONE MARROW TRANSPLANTATION; BRONCHIOLITIS OBLITERANS; CONSANGUINITY; CYTOPENIA; DRUG MEGADOSE; GRAFT FAILURE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; LIVING DONOR; MYOCARDITIS; POLYMYOSITIS; PRIORITY JOURNAL; REVIEW; SEVERE COMBINED IMMUNODEFICIENCY; SURVIVAL TIME;

EID: 78651088006     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2010.11.005     Document Type: Review

References (26)

1. Al-Ghonaium A. Stem cell transplantation for primary immunodeficiencies: King Faisal Specialist Hospital experience from 1993 to 2006. Bone Marrow Transplant 2008, 42(Suppl 1):S53-S56.
2. Antoine C., Müller S., Cant A., et al. European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency. Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968-99. Lancet 2003, 361(9357):553-560.
3. Grunebaum E., Mazzolari E., Porta F., et al. Bone marrow transplantation for severe combined immune deficiency. JAMA 2006, 295(5):508-518.
4. Caillat-Zucman S., Le Deist F., Haddad E., et al. Impact of HLA matching on outcome of hematopoietic stem cell transplantation in children with inherited diseases: a single-center comparative analysis of genoidentical, haploidentical or unrelated donors. Bone Marrow Transplant 2004, 33(11):1089-1095.
5. O'Reilly R.J., Dupont B., Pahwa S., et al. Reconstitution in severe combined immunodeficiency by transplantation of marrow from an unrelated donor. N Engl J Med 1977, 297(24):1311-1318.
6. Buckley R.H., Schiff S.E., Schiff R.I., et al. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 1999, 340(7):508-516.
7. Dror Y., Gallagher R., Wara D.W., et al. Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. Blood 1993, 81(8):2021-2030.
8. Fischer A., Landais P., Friedrich W., et al. European experience of bone-marrow transplantation for severe combined immunodeficiency. Lancet 1990, 336(8719):850-854.
9. Gennery A.R., Dickinson A.M., Brigham K., et al. CAMPATH-1M T-cell depleted BMT for SCID: long-term follow-up of 19 children treated 1987-98 in a single center. Cytotherapy 2001, 3(3):221-232.
10. Mazzolari E., Forino C., Guerci S., et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol 2007, 120(4):892-899.
11. Petrovic A., Dorsey M., Miotke J., et al. Hematopoietic stem cell transplantation for pediatric patients with primary immunodeficiency diseases at All Children's Hospital/University of South Florida. Immunol Res 2009, 44(1-3):169-178.
12. Roifman C.M., Grunebaum E., Dalal I., et al. Matched unrelated bone marrow transplant for severe combined immunodeficiency. Immunol Res 2007, 38(1-3):191-200.
13. Tsuji Y., Imai K., Kajiwara M., et al. Hematopoietic stem cell transplantation for 30 patients with primary immunodeficiency diseases: 20 years experience of a single team. Bone Marrow Transplant 2006, 37(5):469-477.
14. Dalal I., Reid B., Doyle J., et al. Matched unrelated bone marrow transplantation for combined immunodeficiency. Bone Marrow Transplant 2000, 25(6):613-621.
15. Filipovich A.H., Shapiro R.S., Ramsay N.K., et al. Unrelated donor bone marrow transplantation for correction of lethal congenital immunodeficiencies. Blood 1992, 80(1):270-276.
16. Rao K., Amrolia P.J., Jones A., et al. Improved survival after unrelated donor bone marrow transplantation in children with primary immunodeficiency using a reduced-intensity conditioning regimen. Blood 2005, 105(2):879-885.
17. Bertrand Y., Landais P., Friedrich W., et al. Influence of severe combined immunodeficiency phenotype on the outcome of HLA non-identical, T-cell-depleted bone marrow transplantation: a retrospective European survey from the European group for bone marrow transplantation and the European society for immunodeficiency. J Pediatr 1999, 134(6):740-748.
18. Roifman C.M., Somech R., Grunebaum E. Matched unrelated bone marrow transplant for T+ combined immunodeficiency. Bone Marrow Transplant 2008, 41(11):947-952.
19. Mazzolari E., Moshous D., Forino C., et al. Hematopoietic stem cell transplantation in Omenn syndrome: a single-center experience. Bone Marrow Transplant 2005, 36(2):107-114.
20. Borghans J.A., Bredius R.G., Hazenberg M.D., et al. Early determinants of long-term T-cell reconstitution after hematopoietic stem cell transplantation for severe combined immunodeficiency. Blood 2006, 108(2):763-769.
21. Bhattacharya A., Slatter M.A., Chapman C.E., et al. Single centre experience of umbilical cord stem cell transplantation for primary immunodeficiency. Bone Marrow Transplant 2005, 36(4):295-299.
22. Storb R., Deeg H.J., Whitehead J., et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986, 314(12):729-735.
23. Somech R., Kavadas F.D., Atkinson A., et al. High-dose methylprednisolone is effective in the management of acute graft-versus-host disease in severe combined immune deficiency. J Allergy Clin Immunol 2008, 122(6):1215-1216.
24. Bulley S.R., Benson L., Grunebaum E., et al. Cardiac chamber hypertrophy following hematopoietic stem cell transplantation for primary immunodeficiency. Biol Blood Marrow Transplant 2008, 14(2):229-235.
25. Grunebaum E., Bates A., Roifman C.M. Omenn syndrome is associated with mutations in DNA ligase IV. J Allergy Clin Immunol 2008, 122(6):1219-1220.
26. Neven B., Leroy S., Decaluwe H., et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood 2009, 113(17):4114-4124.